Neuland Laboratories
NEULANDLAB.NSNEULANDLAB.NS · Stock Price
Historical price data
Overview
Neuland Laboratories is a mission-driven, pure-play API CDMO that partners with pharmaceutical and biotech companies to accelerate and de-risk the development and manufacturing of complex molecules. The company has achieved significant scale, serving over 500 clients in 80+ countries with a strong regulatory footprint across major global health authorities. Its strategy is centered on deepening its capabilities in high-value niche technologies like peptides, highly potent APIs (HPAPIs), and antibody-drug conjugate (ADC) linkers, while expanding its capacity to capture the growing trend of outsourcing by innovators.
Technology Platform
Proprietary expertise in complex chemical synthesis, process development, and scale-up manufacturing for APIs, with specialized capabilities in peptides, HPAPIs, and ADC linkers/payloads.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Neuland competes with global CDMOs like Lonza and Catalent, Indian peers like Divi's Laboratories, and cost-aggressive Chinese manufacturers. Its differentiation lies in a pure-play API focus, deep expertise in complex synthesis and niche technologies (peptides, HPAPIs), and a strong regulatory track record, allowing it to command a premium in high-value segments.